Skip to main content
REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.25
-0.38 (-3.95%)
Nov 21, 2024, 12:09 PM EST - Market open

REGENXBIO Revenue

REGENXBIO had revenue of $24.20M in the quarter ending September 30, 2024, a decrease of -16.31%. This brings the company's revenue in the last twelve months to $84.33M, down -15.14% year-over-year. In the year 2023, REGENXBIO had annual revenue of $90.24M, down -19.94%.

Revenue (ttm)
$84.33M
Revenue Growth
-15.14%
P/S Ratio
5.46
Revenue / Employee
$245,137
Employees
344
Market Cap
458.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202390.24M-22.48M-19.94%
Dec 31, 2022112.72M-357.62M-76.03%
Dec 31, 2021470.35M315.78M204.30%
Dec 31, 2020154.57M119.33M338.70%
Dec 31, 201935.23M-183.27M-83.88%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.55B
Pharming Group 285.75M
Fulgent Genetics 277.76M
Talkspace 181.29M
PureTech Health 468.00K
Altimmune 52.00K
Revenue Rankings

RGNX News

More News